IL-13 attenuates gastrointestinal candidiasis in normal and immunodeficient RAG-2-/- mice via peroxisome proliferator-activated receptor- γ activation

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 4939-4947

  Coste, Agnès ^a,b   Lagane, Céline ^a   Filipe, Cédric ^d   Authier, Héiène ^a   Galès, Amandine ^a   Bernad, José ^a   Douin Echinard, Victorine ^d   Lepert, Jean Claude ^a   Balard, Patricia ^a   Linas, Marie Denise ^a,c   Arnal, Jean François ^d   Auwerx, Johan ^b   Pipy, Bernard ^a  

^a Institut Louis Bugnard   (France)

^b CNRS   (France)

^c CHU RANGUEIL   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; INTERLEUKIN 13; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RAG2 PROTEIN; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CELL SURFACE RECEPTOR; DNA BINDING PROTEIN; LECTIN; LIGAND; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR; RAG2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDIASIS; CELL LEVEL; CONTROLLED STUDY; DRUG INHIBITION; FUNGAL COLONIZATION; GASTROINTESTINAL INFECTION; GENE OVEREXPRESSION; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; MACROPHAGE ACTIVATION; MOUSE; MOUTH INFECTION; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ANIMAL; CANDIDA ALBICANS; CECUM; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GASTROINTESTINAL DISEASE; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CECUM; CELL MOVEMENT; DNA-BINDING PROTEINS; FEMALE; GASTROINTESTINAL DISEASES; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERLEUKIN-13; LECTINS, C-TYPE; LIGANDS; MACROPHAGES; MANNOSE-BINDING LECTINS; MICE; MICE, KNOCKOUT; PPAR GAMMA; RECEPTORS, CELL SURFACE; THIAZOLIDINEDIONES;

EID: 44449150382     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.4939     Document Type: Article

References (50)

1. Dupont, P. F. 1995. Candida albicans, the opportunist: a cellular and molecular perspective. J. Am. Podiatr. Med. Assoc. 85: 104-115.
2. Stahl, P. D., and R. A. Ezekowitz. 1998. The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 10: 50-55.
3. Ezekowitz, R. A., K. Sastry, P. Bailly, and A. Warner. 1990. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J. Exp. Med. 172: 1785-1794.
4. Ezekowitz, R. A., D. J. Williams, H. Koziel, M. Y. Armstrong, A. Warner, F. F. Richards, and R. M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351: 155-158.
5. Kabha, K., L. Nissimov, A. Athamna, Y. Keisari, H. Parolis, L. A. Parolis, R. M. Grue, J. Schlepper-Schafer, A. R. Ezekowitz, D. E. Ohman, et al. 1995. Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infect. Immun. 63: 847-852.
6. Coste, A., M. Dubourdeau, M. D. Linas, S. Cassaing, J. C. Lepert, P. Balard, S. Chalmeton, J. Bernad, C. Orfila, J. P. Seguela, and B. Pipy. 2003. PPARγ promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. Immunity 19: 329-339.
7. Yamamoto, Y., T. W. Klein, and H. Friedman. 1997. Involvement of mannose receptor in cytokine interleukin-1 β (IL-1β), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1 β (MIP-1 β ), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect. Immun. 65: 1077-1082.
8. Clohisy, D. R., Z. Bar-Shavit, J. C. Chappel, and S. L. Teitelbaum. 1987. 1,25- Dihydroxyvitamin D3 modulates bone marrow macrophage precursor proliferation and differentiation: up-regulation of the mannose receptor. J. Biol. Chem. 262: 15922-15929.
9. Schreiber, S., S. L. Perkins, S. L. Teitelbaum, J. Chappel, P. D. Stahl, and J. S. Blum. 1993. Regulation of mouse bone marrow macrophage mannose receptor expression and activation by prostaglandin E and IFN-γ J. Immunol. 151: 4973-4981.
10. Coste, A., M. D. Linas, S. Cassaing, J. Bernad, S. Chalmeton, J. P. Seguela, and B. Pipy. 2002. A sub-inhibitory concentration of amphotericin B enhances can- didastatic activity of interferon-γ- and interleukin-13-treated murine peritoneal macrophages. J. Antimicrob. Chemother. 49: 731-740.
11. Raveh, D., B. A. Kruskal, J. Farland, and R. A. Ezekowitz. 1998. Th1 and Th2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis. J. Leukocyte Biol. 64: 108 -113.
12. Finkelman, F. D., T. Shea-Donohue, S. C. Morris, L. Gildea, R. Strait, K. B. Madden, L. Schopf, and J. F. Urban, Jr. 2004. Interleukin-4- and interleu- kin-13-mediated host protection against intestinal nematode parasites. Immunol. Rev. 201: 139 -155.
13. de Waal Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151: 6370-6381.
14. Heydeck, D., L. Thomas, K. Schnurr, F. Trebus, W. E. Thierfelder, J. N. Ihle, and H. Kuhn. 1998. Interleukin-4 and -13 induce upregulation of the murine macro- phage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6. Blood 92: 2503-2510.
15. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy-δ 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ. Cell 83: 803-812.
16. Tontonoz, P., L. Nagy, J. G. Alvarez, V. A. Thomazy, and R. M. Evans. 1998. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252.
17. Terabe, M., T. Kuramochi, T. Hatabu, M. Ito, Y. Ueyama, K. Katakura, S. Kawazu, T. Onodera, and Y. Matsumoto. 1999. Non-ulcerative cutaneous lesion in immunodeficient mice with Leishmania amazonensis infection. Para-sitol. Int. 48: 47-53.
18. Mondon, P., M. P. Brenier, F. Symoens, E. Rodriguez, E. Coursange, F. Chaib, B. Lebeau, M. A. Piens, A. M. Tortorano, M. Mallie, et al. 1997. Molecular typing of Aspergillus fumigatus strains by sequence-specific DNA primer (SSDP) analysis. FEMS Immunol. Med. Microbiol. 17: 95-102.
19. Einsele, H., H. Hebart, G. Roller, J. Loffler, I. Rothenhofer, C. A. Muller, R. A. Bowden, J. van Burik, D. Engelhard, L. Kanz, and U. Schumacher. 1997. Detection and identification of fungal pathogens in blood by using molecular probes. J. Clin. Microbiol. 35: 1353-1360.
20. Loeffler, J., N. Henke, H. Hebart, D. Schmidt, L. Hagmeyer, U. Schumacher, and H. Einsele. 2000. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J. Clin. Microbiol. 38: 586 -590.
21. Tuite, A., A. Mullick, and P. Gros. 2004. Genetic analysis of innate immunity in resistance to Candida albicans. Genes Immun. 5: 576 -587.
22. Vazquez-Torres, A., and E. Balish. 1997. Macrophages in resistance to candidi-asis. Microbiol. Mol. Biol. Rev. 61: 170 -192.
23. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
24. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macro- phage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549 -555.
25. Romani, L. 2000. Innate and adaptive immunity in Candida albicans infections and saprophytism. J. Leukocyte Biol. 68: 175-179.
26. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
27. de Repentigny, L., D. Lewandowski, and P. Jolicoeur. 2004. Immunopathogen- esis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin. Microbiol. Rev. 17: 729 -759, table of contents.
28. Kullberg, B. J., and A. M. Oude Lashof. 2002. Epidemiology of opportunistic invasive mycoses. Eur. J. Med. Res. 7: 183-191.
29. Clemons, K. V., and D. A. Stevens. 2000. Treatment of orogastrointestinal can- didosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-γ. Med. Mycol. 38: 213-219.
30. Clemons, K. V., and D. A. Stevens. 2001. Efficacy of ravuconazole in treatment of mucosal candidosis in SCID mice. Antimicrob. Agents Chemother. 45:3433-3436.
31. Narayanan, R., W. A. Joyce, and R. A. Greenfield. 1991. Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect. Immun. 59: 2116 -2119.
32. Vazquez-Torres, A., J. Jones-Carson, T. Warner, and E. Balish. 1995. Nitric oxide enhances resistance of SCID mice to mucosal candidiasis. J. Infect. Dis. 172: 192-198.
33. Edens, H. A., C. A. Parkos, T. W. Liang, A. J. Jesaitis, J. E. Cutler, and H. M. Miettinen. 1999. Non-serum-dependent chemotactic factors produced by Candida albicans stimulate chemotaxis by binding to the formyl peptide receptor on neutrophils and to an unknown receptor on macrophages. Infect. Immun. 67: 1063-1071.
34. Zhu, K., and U. Mrowietz. 2005. Enhancement of antibacterial superoxide-anion generation in human monocytes by fumaric acid esters. Arch. Dermatol. Res. 297: 170 -176.
35. Villegas, I., A. R. Martin, W. Toma, and C. A. de la Lastra. 2004. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Eur. J. Pharmacol. 505: 195-203.
36. Tontonoz, P., E. Hu, and B. M. Spiegelman. 1995. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ. Curr. Opin. Genet. Dev. 5: 571-576.
37. Berry, A., P. Balard, A. Coste, D. Olagnier, C. Lagane, H. Authier, F. Benoit-Vical, J. C. Lepert, J. P. Seguela, J. F. Magnaval, et al. 2007. IL-13 induces expression of CD36 in human monocytes through PPARy activation. Eur. J. Immunol. 37: 1642-1652.
38. Huang, J. T., J. S. Welch, M. Ricote, C. J. Binder, T. M. Willson, C. Kelly, J. L. Witztum, C. D. Funk, D. Conrad, and C. K. Glass. 1999. Interleukin-4- dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase Nature 400: 378 -382.
39. Nagy, L., P. Tontonoz, J. G. Alvarez, H. Chen, and R. M. Evans. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93: 229 -240.
40. Serghides, L., and K. C. Kain. 2001. Peroxisome proliferator-activated receptor γ-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plas- modium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-α secretion by monocytes/macrophages. J. Immunol. 166: 6742-6748.
41. Akiyama, T. E., S. Sakai, G. Lambert, C. J. Nicol, K. Matsusue, S. Pimprale, Y. H. Lee, M. Ricote, C. K. Glass, H. B. Brewer, Jr., and F. J. Gonzalez. 2002. Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macro- phages and reduced cholesterol efflux. Mol. Cell. Biol. 22: 2607-2619.
42. Chawla, A., W. A. Boisvert, C. H. Lee, B. A. Laffitte, Y. Barak, S. B. Joseph, D. Liao, L. Nagy, P. A. Edwards, L. K. Curtiss, et al. 2001. A PPAR γ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and athero-genesis. Mol. Cell 7: 161-171.
43. Kaul, D., and P. K. Anand. 2003. Regulation of PPAR-γ gene in human promy-elocytic HL-60 cell line. Leuk. Res. 27: 683-686.
44. Kaul, D., A. Gautam, and K. Sikand. 2006. Importance of LXR-α transcriptome in the modulation of innate immunity. Mol. Cell. Biochem. 292: 53-57.
45. Valledor, A. F. 2005. The innate immune response under the control of the LXR pathway. Immunobiology 210: 127-132.
46. Rieusset, J., J. Seydoux, S. I. Anghel, P. Escher, L. Michalik, N. Soon Tan, D. Metzger, P. Chambon, W. Wahli, and B. Desvergne. 2004. Altered growth in male peroxisome proliferator-activated receptor γ (PPARγ) heterozygous mice: involvement of PPARγ in a negative feedback regulation of growth hormone action. Mol. Endocrinol. 18: 2363-2377.
47. Rousseaux, C., B. Lefebvre, L. Dubuquoy, P. Lefebvre, O. Romano, J. Auwerx, D. Metzger, W. Wahli, B. Desvergne, G. C. Naccari, et al. 2005. Intestinal an- tiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome pro- liferator-activated receptor-γ. J. Exp. Med. 201: 1205-1215.
48. Collin, M., N. S. Patel, L. Dugo, and C. Thiemermann. 2004. Role of peroxisome proliferator-activated receptor-γ in the protection afforded by 15-deoxyδ12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin. Crit. Care Med. 32: 826 -831.
49. Dugo, L., M. Collin, S. Cuzzocrea, and C. Thiemermann. 2004. 15d-Prostaglan- din J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria. Eur. J. Pharmacol. 498: 295-301.
50. Liu, D., B. X. Zeng, S. H. Zhang, Y. L. Wang, L. Zeng, Z. L. Geng, and S. F. Zhang. 2005. Rosiglitazone, a peroxisome proliferator-activated receptor-y agonist, reduces acute lung injury in endotoxemic rats. Crit. Care Med. 33: 2309 -2316.